Biotechnology in Italy
- ID: 1923314
- February 2015
- Region: Italy
- 27 pages
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Italian biotechnology industry had total revenues of $9.2bn in 2014, representing a compound annual growth rate (CAGR) of 5.1% between 2010 and 2014.
- The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $3.8bn, equivalent to 41.7% of the industry's overall value.
- The performance of the industry is forecast to decelerate, with an anticipated CAGR of 4.5% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $11.4bn by the end of 2019.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Italy
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Italy economy
Key Questions Answered
What was the size of the Italy biotechnology market by value in 2014?
What will be the size of the Italy biotechnology market in 2019?
What factors are affecting the strength of competition in the Italy biotechnology market?
How has the market performed over the last five years? SHOW LESS READ MORE >
Market value forecast
Market value forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Zambon Company S.p.A.
LIST OF TABLES
Table 1: Italy biotechnology industry value: $ billion, 2010–14(e)
Table 2: Italy biotechnology industry category segmentation: $ billion, 2014(e)
Table 3: Italy biotechnology industry geography segmentation: $ billion, 2014(e)
Table 4: Italy biotechnology industry value forecast: $ billion, 2014–19
Table 5: Gentium S.p.A.: key facts
Table 6: Menarini Group: key facts
Table 7: Zambon Company S.p.A.: key facts
Table 8: Italy size of population (million), 2010–14
Table 9: Italy gdp (constant 2005 prices, $ billion), 2010–14
Table 10: Italy gdp (current prices, $ billion), 2010–14
Table 11: Italy inflation, 2010–14
Table 12: Italy consumer price index (absolute), 2010–14
Table 13: Italy exchange rate, 2010–14
LIST OF FIGURES
Figure 1: Italy biotechnology industry value: $ billion, 2010–14(e)
Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2014(e)
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2014(e)
Figure 4: Italy biotechnology industry value forecast: $ billion, 2014–19
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2014
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2014
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2014
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2014
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2014
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2014